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I N T R O D U C T I O N  
 
In 1989, officials in Miami-Dade County, Florida established the nation’s first drug 
court. This special court was designed to bring drug treatment more fully into the 
criminal justice system, treating offenders with a history of drug abuse for their 
addiction, while simultaneously ensuring supervision, and sanctions when needed, 
from the courts.  The movement for an alternative court to sentence drug offenders 
emerged from the rapidly evolving reality that the nation’s decision to address drug 
abuse through law enforcement mechanisms would continue to pose significant 
challenges for the criminal court system.  In 2004, 53% of persons in state prison 
were identified with a drug dependence or abuse problem, but only 15% were 
receiving professional treatment.1 Drug-related crime continues to present a costly 
burden to American society, one that supply reduction efforts have failed to stem. In 
2001, the Office of National Drug Control Policy estimated that in 1998 illegal drug 
use cost Americans $31.1 billion in criminal justice expenses, $30.1 billion in lost 
productivity and $2.9 billion in costs related to property damage and victimization.2
 
Since 1989, drug courts have spread throughout the country; there are now over 
1,600 such courts operating in all 50 states. The drug court movement reflects a 
desire to shift the emphasis from attempting to combat drug crimes by reducing the 
supply of drugs to addressing the demand for drugs through the treatment of 
addiction. Drug courts use the criminal justice system to address addiction through 
an integrated set of social and legal services instead of solely relying upon sanctions 
through incarceration or probation.  This report surveys a range of research 
conducted on drug courts to date. Its aim is to outline general findings on the 
workings and efficacy of drug courts nationwide and to highlight potential concerns 
and areas where more research is needed.   
 
1 Christopher J. Mumola and Jennifer C. Karberg, Drug Use and Dependence, State and Federal 
Prisoners, 2004, Bureau of Justice Statistics, NCJ 213530, 2006. 
2 Steven Belenko, Economic Benefits Of Drug Treatment: A Critical Review of the Evidence for Policy 
Makers, Treatment Research Institute at the University of Pennsylvania, 2005, p. 2. 





Despite general indications of drug court efficacy, nearly two decades after their 
introduction a number of questions remain.  Because drug courts are designed and 
operated at the local level, there are fundamental differences that make cross-
jurisdictional comparisons difficult.  While the general framework may be portable 
from program to program – a diversion program for certain categories of low-level 
defendants who have demonstrated a linkage between their drug abuse and criminal 
offending – specific selection criteria, protocols for adjudication, means of 
supervision and revocation procedures can differ dramatically.  The localism that 
defines drug court design complicates efforts to identify best practices.  However, we 
can identify specific elements from different drug courts that are critical ingredients 
for a successful program.  The foundation of a vibrant and sustainable drug diversion 
program rests both on indicators of success and learning and adapting to emerging 
challenges. 
  





                                                
H O W  D O  D R U G  C O U R T S  W O R K ?  
 
A number of elements define the operation of drug courts, although with variation 
based on background of the defendant population, legal issues, and other factors.  




There are generally two models for drug courts: deferred prosecution programs and 
post-adjudication programs.  In a deferred prosecution or diversion setting, 
defendants who meet certain eligibility requirements are diverted into the drug court 
system prior to pleading to a charge. Defendants are not required to plead guilty and 
those who complete the drug court program are not prosecuted further. Failure to 
complete the program, however, results in prosecution. Alternatively, in the post-
adjudication model, defendants must plead guilty to their charges but their sentences 
are deferred or suspended while they participate in the drug court program. 
Successful completion of the program results in a waived sentence and sometimes an 
expungement of the offense.  However, in cases where individuals fail to meet the 
requirements of the drug court (such as a habitual recurrence of drug use), they will 




Though eligibility requirements differ by court, generally defendants must be 
charged with drug possession or a non-violent offense and must have tested positive 
for drugs or have an established substance abuse problem at the time of arrest.3  For 
drug courts receiving federal funding through the Bureau of Justice Assistance, there 
is a requirement to exclude persons with a current or prior violent offense.  While the 
 
3 A growing percentage of courts, however, have begun accepting offenders with prior convictions for 
violent offenses into their programs. Reginald Fluellen and Jennifer Trone, Do Drug Courts Save Jail 
and Prison Beds? Vera Institute of Justice, 2000, p. 5. 





exclusion of persons with a history of violent offending, whether required by state or 
federal regulations, is premised on public safety grounds, there is some question as to 
whether such an exclusion truly serves the interest of public safety.  In particular, the 
definition of a violent offense can include the mere possession of a weapon at the 
time of arrest, even if it was not presented, brandished, or used.  Also, persons who 
are currently facing charges for a drug offense may be denied entry into the drug 
court because of a past, wholly unrelated offense.  These narrow criteria for drug 
court participation have consequences for the potential overall diversionary impact of 
the programs. 
 
Programming and Sanctions 
 
Programs typically run between six months and one year, though many participants 
remain in the program for longer. Participants must complete the entire program 
cycle in order to graduate. Successful completion in all programs is contingent upon 
remaining drug-free and without arrests for a specified period of time. Participants 
must attend frequent status hearings with the judge who, along with judicial and 
clinical staff, monitors the progress of each individual.  
 
A participant who is non-compliant with any of the drug court protocols can be 
sanctioned through a variety of means, including increased status hearings, drug tests 
or jail time.  This is a key juncture in which both program design and judicial 
discretion have a demonstrable impact in shaping outcomes.  Some situations, such 
as an individual refusing to continue participation in a treatment program, will result 
in termination and likely lead to the individual being taken into custody.  But for 
persons who have violated the terms of their drug court sentence by relapsing, for 
example, a judge can exercise discretion in determining how to proceed.  This may 
include modification of the treatment or imposing some type of sanction, including a 
brief period of incarceration.  For a drug court system to be a viable diversion 
instrument for individuals who have a history of substance abuse, it must factor 
relapse and a flexible cadre of judicial responses into its design. 





                                                
After two decades of implementation, research shows that many drug courts reduce 
recidivism and save taxpayer dollars. Evidence from a number of studies (collecting 
data from between 1 and 95 drug courts) shows that drug court graduates are 
rearrested less than comparison groups.4 The reduction in rearrest rates is the 




Graduates of drug courts are, according to current evaluations, less likely to be 
rearrested than persons processed through traditional court mechanics. Findings 
from drug court evaluations show that participation in drug courts results in fewer 
rearrests and reconvictions, or longer periods between arrests.  
 
• An analysis of research findings from 76 drug courts found a 10% reduction 
in rearrest, with pre-adjudication courts experiencing a 13% decline in 
rearrest.6 
• An analysis of 30 drug court evaluations found an average 13% decline in the 
rate of reconvictions for a new offense.7 
• A meta-analysis of 57 studies estimated that participation in a drug court 
program would produce an 8% decline in crime relative to no treatment.8 
• A Government Accountability Office report found that 13 of 17 courts 
reporting on post-program recidivism measured reductions between 4 and 25 
percentage points in rearrests and reconvictions.9 
 
4 National Institute of Justice, Drug Courts: The Second Decade, 2006, p. 7; Belenko, 2001, pp. 30-31; 
Government Accountability Office, Adult Drug Courts: Evidence Indicates Recidivism Reductions and 
Mixed Results for Other Outcomes, 2005, p.44. 
5 Belenko, 2005, p. 44 – 46; Belenko, 2001, p. 42- 43. 
6 Shaffer, p. 4. 
7 Barnoski & Aos, p. 4. 
8 Steve Aos, Marna Miller, and Elizabeth Drake, Evidence-Based Public Policy Options to Reduce Future 
Prison Construction, Criminal Justice Costs, and Crime Rates, Washington State Institute for Public 
Policy, 2006, p. 9. 
9 Government Accountability Office, p. 52. 





                                                
• An evaluation of drug courts in Florida and Missouri, which tracked drug 
court participant progress for 24 months, found a substantially lower rearrest 
rate for drug court graduates relative to the comparison group: 12% vs. 40% 
in Florida and 45% vs. 65% in Missouri.10  These represent a reduction in 
rearrest rates of 70% and 31%, respectively. 
• Six drug courts in New York State averaged a 29% reduction in rearrest 
measured over 3 years following participants’ initial arrest.11  
• Recent research suggests that these reductions in rearrest extend beyond the 
first few years following treatment.  An evaluation of the Multnomah 
County, Oregon drug court found a 24% reduction in drug arrests for 
participants thirteen years after initial entry into the program.12  
 
While it is generally accepted that drug courts effectively reduce rearrest rates relative 
to simple probation or incarceration, there is some reason to be cautious when 
interpreting these results.  Some studies show little or no impact from drug court 
participation and it can be difficult to specify which components of the program or 
the research design may be contributing to these results.   
 
For example, are the evaluation models appropriately specifying relevant factors that 
may impact outcomes, but are external to the treatment design?  Gender, age, race, 
socioeconomic background, criminal history, and substance abuse history have all 
been shown to impact treatment outcomes.13  Many of these variables are not 
accounted for in analyses of drug court effectiveness.  Operationalizing drug court 
variables can be difficult and outcome measures may be reflecting the interaction of 
these variables with the treatment modality.   
 
10 Belenko, 2001, p. 30 – 35. 
11 Michael Rempel, Dana Fox-Kralstein, Amanda Cissner, Robyn Cohen, Melissa Labriola, Donald 
Farole, Ann Bader, and Michael Magnani, The New Your State Adult Drug Court Evaluation: Policies, 
Participants, and Impacts (Executive Summary), Center for Court Innovation, 2003, p. 2. 
12 Michael W. Finigan, Shannon M. Carey, and Anton Cox, The Impact of a Mature Drug Court Over 
10 Years of Operation: Recidivism and Costs, NPC Research, 2007, p. 28. 
13 Michael Rempel and Christine Depies Destefano, “Predictors of Engagement in Court-Mandated 
Treatment: Findings at the Brooklyn Treatment Court, 1996-2000,” Drug Courts In Operation: 
Current Research, 2001, pp. 91-93. 





                                                
Additionally, definitions of recidivism and the length of time that recidivism is 
measured differ among the studies, making an absolute comparison difficult.  Some 
drug court evaluations have measured rearrest rates without distinguishing between 
participants currently under supervision and those who have completed the program.   
This is important because drug court participants who graduate tend to have much 
lower recidivism rates than drug court dropouts.14 Some studies suggest that among 
drug court dropouts, time spent in treatment had little if any effect on post-program 
recidivism.15  This suggests that drug courts experiencing a less than desired effect on 
rearrest rates may want to focus on addressing the program design to encourage 
higher rates of retention. 
 
Researchers have also noted that the composition of drug court participants needs to 
be addressed appropriately in developing a court model.  For example, an evaluation 
of California’s Proposition 36 diversion program for low-level drug offenders found 
that almost half of the persons who were receiving treatment for the first time had 
been using drugs for more than 10 years, and one in five had been using for more 
than 20 years.16  While the Proposition 36 is not a drug court model, it does 
illustrate that some treatment programs may be working with a population with a 
mature drug using history, which are unlikely to respond to the same programming 
as a population that has been using drugs for a shorter period.  Thus, any evaluation 
of drug court outcomes must consider the drug abuse history of the people entering 
the program.  
 
 
14 Government Accountability Office, p. 62. 
15 Rempel, et al., p 5. 
16 Darren Urada and Douglas Longshore, Evaluation of the Substance Abuse and Crime Prevention Act, 
Final Report, UCLA & Integrated Substance Abuse Programs, April 2007. 





                                                
Cost Savings 
 
Evaluations of the net costs and benefits of drug courts nationwide generally find 
that drug courts save taxpayer dollars compared to simple probation and/or 
incarceration, primarily due to reductions in arrests, case processing, jail occupancy 
and victimization costs.  While not all persons diverted to drug court would have 
otherwise been sentenced to prison, for those individuals who are incarcerated, the 
average annual cost is estimated to be $23,000 per inmate, while the average annual 
cost of drug court participation is estimated to be $4,300 per person. A number of 
key evaluations have reported the following:  
 
• In 2005, the Government Accountability Office found that seven drug courts 
evaluated had net benefits of between $1,000 and $15,000 per participant 
due to reduced recidivism and avoided costs to potential victims.17 
• Evaluations of 11 drug courts in Oregon, Washington, Kentucky and 
Missouri found substantial cost savings.  The Oregon drug court was 
estimated to save $3,500 per participant due to reduced recidivism and 
incarceration.  Six drug courts in Washington saved an average of $6,800 per 
participant based on reduced reaarrests and victimization costs.18 
• A study of five drug courts in Washington found $1.74 in benefits for every 
dollar invested in drug courts.19  This benefit results from reduced court costs 
associated with a decline in recidivism. 
• A study in St. Louis found that the initial cost of drug courts ($7,800 per 
graduate) exceeded that of someone completing simple probation ($6,300 
per person), but two years after the completion of the program, drug court 
graduates were realizing a net savings of $2,600 per person resulting from 
lower jail costs, reduced crime victimization, and healthcare costs. 20 
 
17 Government Accountability Office, p. 7 
18 Belenko, 2005, pp. 44-45 
19 Barnoski and Aos, p. 11. 
20 Belenko, 2005, p. 45 





                                                
• A 1997 national survey of court administrators in 97 drug courts reported 
savings of as much as $400,000 per year accumulated from the reduction in 
pre-trial stays and jail beds alone.21  
• The Multnomah County evaluation found that ten years of operating a drug 
court resulted in $9 million in savings based on case processing alone. Taking 
into account factors such as reduced recidivism and jail time and the savings 
due to reduced victimization, the court saved taxpayers $88 million.22 
• Two counties in Michigan reported cost savings of $1 million over a two-year 
period (or $3,000 per participant) from fewer rearrests, less probation 
supervision time and fewer new court cases.23 
 
The Effect of Sanctions  
 
A 1997 publication released by the National Association of Drug Court Professionals 
(NADCP) documents the 10 key components to a successful drug court design.24  
Component #6 outlines the use of rewards and sanctions as instruments to address 
compliance problems.  The NADCP recognizes that “addiction is a chronic, 
relapsing condition” and that abstinence from drug abuse “is a learning experience, 
and each relapse to [alcohol and other drug] use may teach something about the 
recovery process.”25  In order to account for relapse and other violations that will 
likely occur during a course of treatment, the NADCP recommends that court 
administrators use a system of graduated responses.  Developing a system of both 
graduated rewards and sanctions recognizes that “there is value in . . . incremental 
progress toward the goal” of abstinence.26  A participant who faithfully makes all 
court appearances and meets the obligations of the court may be rewarded with an 
acknowledgement of accomplishment.   
 
21 Fluellen and Trone, p. 1 
22 Finigan, et al., pp. 45 and 50 
23 Michigan Supreme Court, Michigan Drug Treatment Court Performance Review, Michigan Supreme 
Court, State Court Administrative Office, 2007, p. 1. 
24 The National Association of Drug Court Professionals, Defining Drug Courts: The Key Components, 
January 1997. 
25 Ibid, p.  23. 
26 Ibid. 





                                                
In programs such as the Washington, D.C. drug court, participants who meet certain 
milestones receive a certificate at a public ceremony at the court.  In addition, people 
who are currently in the program can attend the graduation ceremony to witness 
first-hand the ultimate goal of completing treatment.  In contrast, persons who 
repeatedly miss required court appearances or fail drug testing, for example, may be 
subject to a range of sanctions.  These may run the gamut from a warning by the 
judge, increased supervision by the court, or a limited stay in jail.  While the aim of 
the drug court is to keep the treatment protocol flexible enough to address the 
violation while keeping the person in the program, repeated violations can result in 
expulsion from the drug court program and the commencement of conventional 
court proceedings. 
 
In practice, courts tend to implement sanctions and rewards for a variety of reasons 
and under different circumstances. Regarding sanctions, the National Institute of 
Justice as well as a New York State drug court evaluation noted that many courts do 
not have a formal system under which sanctions are imposed, nor are records kept for 
when and why sanctions are enforced.27  This is problematic when attempting to 
evaluate the efficacy of a drug court intervention.  An evaluation of drug courts in 
Kings, Queens, and Suffolk Counties in New York found that “none routinely 
follow a ‘graduated sanctions’ model, where successive infractions are met with 
increasingly severe sanctions” and drug court personnel “frequently make 
individualized decisions based on what they believe will be more effective.”28  While 
flexibility should be a hallmark of a well-designed drug court, running a court in the 
manner described above threatens inconsistent and arbitrary outcomes.  Of the three 
courts studied in-depth on sanction use in New York, certain infractions were always 
met with the same sanction regardless of how many violations a participant had 
committed. For example, an arrest or the issuing of a warrant to a participant was 
always met with jail time in the Brooklyn court.29  Jail sanctions were the most 
 
27 National Institute of Justice, p. 17; see also, Rempel, et al., p. 6 
28 Rempel, et al., p. 6 
29 Ibid. 





                                                
common form of sanctions used in the reporting courts in New York City, with most 
stays 11 days or less.30
 
The utility of relying upon sanctions as a means of ensuring program compliance 
presents a nuanced picture. Some evaluations have noted the following:  
 
• A GAO evaluation of 16 drug courts found that the severity of sanctions was 
not an accurate predictor of program completion.31  
• An evaluation of a Clark County, Nevada drug court documented that 
imposing any sanction was associated with a higher rearrest rate and lower 
graduation rates.32  The evaluation did not establish, however, whether the 
higher failure rate was related to the use of sanctions or to the profile of the 
participants. 
• A Washington, DC pre-trial diversion court for drug offenders reported 
lower rates of drug use and rearrest among persons who were subjected to 
regular judicial supervision, drug testing, and potential sanctions compared 
to traditional processing of drug defendants.33 
• A study of a court-mandated drug treatment program in Brooklyn, NY 
found the strongest predictor of treatment success was the threat of “legal 
coercion.”  Those individuals who faced more severe consequences in terms 
of potential incarceration should they fail to complete the treatment program 
achieved better retention rates.34  
 
 
30 Michael Rempel, Dana Fox-Kralstein, Amanda Cissner, Robyn Cohen, Melissa Labriola, Donald 
Farole, Ann Bader, and Michael Magnani, The New York State Adult Drug Court Evaluation: Policies, 
Participants, and Impacts, Center for Court Innovation, 2003(a), p. 68. 
31 Government Accountability Office, p.62 
32 National Institute of Justice, p.7 
33 Adele V. Harrell, Shannon E. Cavanagh, and John Roman, Findings from the Evaluation of the D.C. 
Superior Court Drug Intervention Program, The Urban Institute, 1998, pp. 134-145. 
34 Rempel and Destefano, p. 107. 





                                                
The data on sanctions presents a mixed picture.  It may be that sanctions alone are 
not effective predictors of success, but in conjunction with other program elements 
can play an important role in leading to elevated retention rates.  There is also some 
evidence suggesting that the implementation of sanctions is uneven in many courts, 
which might explain differential outcomes.  Any consideration of the role of 
sanctions in a drug court environment provides important insight into intermediate 
steps that drug court administrators may take to avoid future rearrest.  If sanctions 
are correlated with reduced program retention and elevated rearrest rates, the need 
for sanctions early on in treatment may be seen as an indicator that a participant is at 
a higher risk of failure.  This provides the drug court administrators with the 
opportunity to revisit the treatment program and make any necessary adjustments in 
the interest of preventing future problems.  Developing a flexible, graduated sanction 
program is a crucial contributor to a successful drug court program, because “even 
those who are eventually successful in drug court tend first to relapse, warrant, and 
violate other program rules.”35  Thus, the sanction process should be seen as an 
opportunity to adjust treatment to limit subsequent relapse, rather than the first step 
on the path to an eventual termination of drug court participation and a likely 
sentence to custody. 
 
The Role of the Judge 
 
One of the unique aspects of the drug court model is the frequency with which 
judges interact with participants.  The drug court judge’s role is a continuing 
partnership with the participants that does not end at adjudication. The relationship 
is less formalistic than in traditional courtrooms and is individualized based on the 
judge’s supervision of an individual’s progress.36 As with other metrics used to 
 
35 Rempel, et al., 2003(a), p. 65. 
36 The appropriateness of placing judges in this role has been called into question by some 
commentators. Judge Morris Hoffman of the Denver District Court in Colorado contends that judges 
are not social workers and that placing them in such a position stretches them beyond their 
appropriate judicial function. While the coercive nature of drug court treatment is one of the most 
heralded aspects leading to its successes, Judge Hoffman asserts that the judicial branch should simply 
not be forcing medical treatment upon individuals in return for more lenient sentences. The criminal 





                                                                                                                                    
determine the effectiveness of a drug court intervention, there remains some mixed 
evidence as to the role that a judge should play in the drug court process.   
 
• The GAO report in 2005 noted that the demeanor and conduct of the judge 
did not predict a participant’s success or failure. 37 
• However, a series of studies have found that, while the judge did not appear 
to have an impact on program attendance, drug use, or criminal activity 
among drug court participants, there was an effect when examined by type of 
client.38  Higher risk drug court participants (those with prior failed 
treatment episodes, for example) experienced a benefit from more intense 
judicial involvement, while lower risk participants did not receive any benefit.  
In one study, “[o]ver 80 percent of participants with a prior drug treatment 
history graduated from the program when there were assigned to bi-weekly 
hearings, compared to less than 20 percent of those assigned to as-needed 
hearings.”39 
 
Thus, it appears that a judge may play an important role in determining drug court 
outcomes, but that the impact differs based on the client base.  This is additional 
evidence in support of a drug court model that permits the staff to craft an 
individualized response of graduated sanctions based on each client’s personal drug 
abuse and criminal history.   
 
In addition, courts with a longer history of implementation have had the opportunity 
to monitor a number of judges as they cycle through the system. The evaluation of 
the Multnomah County drug court has done the most to evaluate some of the effects 
of multiple and rotating judges. They report the following:  
 
 
justice system, he contends, should be an end in itself, not an end to something else.  Morris B. 
Hoffman, “The Drug Court Scandal,” North Carolina Law Review, June 2000, p. 1477. 
37 Government Accountability Office, p.62 
38 Douglas B. Marlowe, David S. Festinger, and Patricia A. Lee, “The Judge is a Key Component of 
Drug Court,” National Drug Court Institute Drug Court Review, Vol. 4 (2), 2004, pp. 1-34. 
39 Ibid, p. 18. 





                                                
• Judges serving multiple rotations on the court had better results in terms of 
reductions in rearrests.40 
• Participants who saw one or two judges only were far less likely to be 
terminated early and less likely to miss treatment sessions.41  
 
In addition to the data from the Multnomah County drug court suggesting that the 
judge plays a key role in shaping the outcomes of clients in treatment, a focus group 
study of participants and staff in three New York drug court programs pointed to the 
importance of the judge in program success.42  By and large, judges were described as 
caring and compassionate, but strict when appropriate.  Participants stated that the 
“hands-on role of the judge” and “intensive monitoring and drug testing” were 
helpful in retaining them in the program.  In addition, the rewards and sanctions 
offered by drug court judges were important components to a successful completion 




Few evaluations have provided analysis on how the modality of treatment that drug 
court participants receive impacts their rates of success. The diverse range of 
participants accepted by drug courts makes it difficult to analyze practices 
nationwide, though it has been suggested that drug courts may not best serve those 
with the most serious addictions or those who use the hardest drugs.  This is of 
significant concern in light of the findings from California’s Proposition 36, which 
suggest that there is a substantial population of individuals with mature drug use 
histories who have never received any treatment.  Thus, a person with a drug-using 
past of this type will likely need a very different treatment protocol than someone 
who has only been using drugs for a limited time.  It is crucial to disentangle failures 
 
40 Finigan, et al., p.39 
41 National Institute of Justice, p.10-11; Amanda B. Cissner and Michael Rempel, The State of Drug 
Court Research: Moving Beyond ‘Do They Work?’, Center for Court Innovation, 2005, p. 11. 
42 Donald J. Farole, Jr. and Amanda B. Cissner, Seeing Eye To Eye?:Participant and Staff Perspectives on 
Drug Courts, Center for Court Innovation, 2005, pp. 14-16. 





                                                
of drug treatment due to an individual’s reticence to complete treatment from those 
resulting from persons who were simply placed in a program that was inappropriate 
for their needs.  
 
Criminologists Faith Lutze and Jacqueline van Wormer argue that for those who do 
have serious drug addiction problems, drug courts may not be an effective solution.  
For these persons, more intensive and long-term inpatient treatment would be the 
preferred strategy.  Treatment specialists recognize that addiction is a complex bio-
behavioral disorder; in curing addiction, patients often experience many relapses into 
drug use as they attempt to break their pattern of abuse.43 In drug courts, relapses are 
dealt with both through treatment and punishment. Eventually, a participant with a 
number of relapses or who has failed to comply with protocol will be dismissed from 
the program and subject to prosecution. 
 
Research on drug courts reflects this reality; studies have noted that even those who 
graduate from drug court programs experience relapses and commit other violations 
of their program during their recovery.44 Meanwhile, persons using more serious 
drugs and with the most severe addiction problems may be left out of drug court 
programs because of their criminal history. New practices of admitting higher-level 
offenders are an improvement from past models. The GAO reports that three-
quarters of courts nationwide admit repeat offenders and 16% admit offenders with a 
history of violent crime.45 The question remains then, as to whether those who 
graduate drug court treatment tend to be those with less serious addictions, while 
those with significant addiction problems end up in jail?46  
 
There is also a concern about the time it takes to place an individual in a drug court 
program (the lag between being assigned to a drug court and beginning active 
 
43 Faith E. Lutze and Jacqueline van Wormer, “The Nexus Between Drug and Alcohol Treatment 
Program Integrity and Drug Court Effectiveness,” Criminal Justice Policy Review, Vol. 18, No. 3, 
2007 p. 226-245.   
44 Rempel, et al., 2003(a), p.65.  
45 Fluellen and Trone, p. 5.   
46 Hoffman, p. 1476. 





                                                
treatment) and the length of the treatment protocol.  A study of a treatment court in 
Brooklyn found that a critical predictor of success was whether a defendant was 
placed in treatment within 30 days.47  This is of particular concern in light of the fact 
that some drug court programs suffer from a scarcity of treatment slots.  This is even 
more of a challenge for women, who Rempel and DeStefano found, were likely to 
have to wait twice as long as men for an open treatment slot.  If a drug court cannot 
overcome capacity issues, the likelihood of relapse will increase before an individual is 
even able to begin treatment.  The length of time in treatment is also crucial to 
success.48  Some studies suggest that a minimum stay of 90 days is necessary for a 
successful outcome.  If drug courts are scrambling to find available slots, it is likely 
that the duration of treatment will suffer.   
 
Lutze and van Wormer suggest that drug courts need to take better account of the 
multifarious needs of clients with substance abuse problems. Continual drug 
addiction is the result of a series of factors, including a patient’s environment, socio-
economic status and opportunity. Treatment for drug addiction then, should 
respond to the complex needs of participants. Medical and legal assistance should be 
combined with counseling and social services that address the root causes of drug 
abuse.49  
 
Impact on Prison Population 
 
The Vera Institute of Justice is also concerned that the use of sanctions has resulted 
in participants spending more time in jail than they would have had they never 
enrolled in the drug court program. Because most individuals who enter drug court 
are convicted of non-violent offenses, many would have experienced short, if any, 
periods in jail. Participants who are punished with sanctions sometimes end up with 
multiple stays in jail.50  
 
47 Rempel and DeStefano, p. 112. 
48 Ibid, p. 88. 
49 Lutze and van Wormer 
50 Fluellen and Trone, p. 6  





                                                
In addition to diverting persons convicted of low-level drug offenses from the 
traditional criminal court system, drug courts were also intended to limit admissions 
to prison of people suffering from drug abuse.  However, there is a growing concern 
that instead of providing an alternative sentencing route for arrestees, drug courts 
actually increase the number of people arrested on drug charges.51 Some studies 
suggest that since drug courts provide an additional venue in which to process 
offenders, law enforcement officials are able to make more arrests of lower level 
offenders.   
 
In the Denver District Court, Judge Morris Hoffman notes that arrest numbers for 
drug crimes increased almost three-fold in the two years following the establishment 
of the drug court. Judge Hoffman contends that the drug court enabled police 
officers to make arrests that they would not have considered before.52 He implies that 
police officers are encouraged to make arrests for low-level drug offenses for which 
they would not have previously because of a perception that the drug court is an 
additional resource for adjudicating claims, as opposed to a diversion meant only for 
those who would have been arrested anyway.  
 
Additionally, there is some evidence suggesting that drug courts may be exacerbating 
existing racial disparities in the prison system.  Marquette Law School Professor 
Michael O’Hear identifies four reasons why drug courts may not address racial 
disparity in incarceration and could make it worse.53  First, because drug court 
participation requires an individual to enter the criminal justice system, racial 
disparities in arrest patterns remain unaffected.  Second, the narrow eligibility criteria 
tend to disqualify persons whose offenses would otherwise result in a prison sentence 
and those with a longer criminal history, thereby disadvantaging African Americans.  
Third, even successful drug court programs have a high failure rate and African 
Americans experience a higher rate of failure than whites due to socioeconomic 
 
51 Michael O’Hear, “Rethinking Drug Courts: Restorative Justice As A Response To Racial Injustice,” 
Stanford Law & Policy Review, 20, 2009, pp. 101-137. 
52 Hoffman, pp. 1502 - 1503 
53 O’hear, pp. 117-120. 





                                                
disadvantaged.  Finally, drug court failures can result in more time in jail or prison 
than simply being adjudicated in the conventional criminal court process.  One study 
found that persons who failed drug court were sentenced to terms two to five times 
longer than persons sentenced in traditional criminal court.54
 
 
54 Ibid, p. 119. 





C O N C L U S I O N  &  R E C O M M E N D A T I O N S  
 
Research to date has consistently reported that drug courts are achieving important 
benefits.  Still largely unknown, however, are the practices which lead to success or 
failure of a drug court. Of great concern is the contention that drug courts could be 
increasing the number of people arrested for drug crimes, instead of decreasing in the 
long term the number of people processed in the criminal justice system. Research 
has not yet focused on determining whether drug court participants would have 
ended up in the criminal justice system if not for the drug court. Increased and 
uniform tracking of participants’ criminal history may answer some concerns about 
the net-widening effects of the drug court. It would also be helpful for future 
research to look at the effects of a pre-plea versus a post-plea model and the use of 
sanctions. Research should continue to monitor the rearrest and reconviction rates of 
both graduates and dropouts, distinguishing between within program rates and post-
program rates. It will continue to be useful to know the demographic of graduates 
along with the rates of recidivism in the years that follow their graduation.   
 
 
 
 
  
 
